Evidence map›Paper›PMID 23401520›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2013

Small molecule inhibitor of lipoteichoic acid synthesis is an antibiotic for Gram-positive bacteria.

Stefan G Richter, Derek Elli, Hwan Keun Kim, Antoni P A Hendrickx, Joseph A Sorg, Olaf Schneewind, Dominique Missiakas

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 64 papers.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

64 citing papers in PubMed, 114 citations in OpenAlex.

  1. Article
  2. Infection and immunity · 2026
    Article
  3. Article
  4. Article
  5. In Silico Lead Identification ofInternational journal of molecular sciences · 2025
    Article
  6. Article
  7. Fighting Antimicrobial Resistance: Innovative Drugs in Antibacterial Research.Angewandte Chemie (International ed. in English) · 2025
    Review
  8. SynthesizedNanomaterials (Basel, Switzerland) · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. TerC Proteins Function During Protein Secretion to Metalate Exoenzymes.bioRxiv : the preprint server for biology · 2023
    Article
  19. Lipoteichoic acid ofFrontiers in immunology · 2023
    Article
  20. Review

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Stefan G RichterArgonne National Laboratory, Argonne, IL 60439, USA.
Derek Elli
Hwan Keun Kim
Antoni P A Hendrickx
Joseph A Sorg
Olaf Schneewind
Dominique Missiakas
Argonne National Laboratory · USUniversity of Chicago · USTexas A&M University · US

Funding

Vaccines and Therapies Against BotulismU54AI057153 · NIAID · UNIVERSITY OF CHICAGO · PI SHUMAN, HOWARD A · 2003 to 2013
$87.6M
NIAID NIH HHS 1-U54-AI-057153NIAID NIH HHS U54 AI057153
6 · The paper itself

Abstract

The current epidemic of infections caused by antibiotic-resistant gram-positive bacteria requires the discovery of new drug targets and the development of new therapeutics. Lipoteichoic acid (LTA), a cell wall polymer of gram-positive bacteria, consists of 1,3-polyglycerol-phosphate linked to glycolipid. LTA synthase (LtaS) polymerizes polyglycerol-phosphate from phosphatidylglycerol, a reaction that is essential for the growth of gram-positive bacteria. We screened small molecule libraries for compounds inhibiting growth of Staphylococcus aureus but not of gram-negative bacteria. Compound 1771 [2-oxo-2-(5-phenyl-1,3,4-oxadiazol-2-ylamino)ethyl 2-naphtho[2,1-b]furan-1-ylacetate] blocked phosphatidylglycerol binding to LtaS and inhibited LTA synthesis in S. aureus and in Escherichia coli expressing ltaS. Compound 1771 inhibited the growth of antibiotic-resistant gram-positive bacteria and prolonged the survival of mice with lethal S. aureus challenge, validating LtaS as a target for the development of antibiotics.

Indexed as

AcyltransferasesAnimalsAnti-Bacterial AgentsCatalytic DomainDisease Models, AnimalDrug Resistance, MicrobialEnzyme InhibitorsLipopolysaccharidesMiceMicrobial Sensitivity TestsMutationPhosphatidylglycerolsSepsisSmall Molecule LibrariesStaphylococcal InfectionsStaphylococcus aureusAcyltransferasesAnti-Bacterial AgentsEnzyme InhibitorsLipopolysaccharideslipoteichoic acidPhosphatidylglycerolsSmall Molecule LibrariesTeichoic Acids

Identifiers

PMID23401520
PMCPMC3587227
OpenAlexW2069974121

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.